Latest From Texas Instruments
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Texas Instruments
- Senior Management
Thomas J Engibous, Chmn, Pres. & CEO
William A Aylesworth, SVP, Treas. & CFO
- Contact Info
Phone: (800) 336-5236
12500 TI Blvd.
Dallas, TX 75243-4136
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.